Ayala Pharmaceuticals, Inc. (AYLA)

NASDAQ: AYLA · IEX Real-Time Price · USD
1.59
-0.02 (-1.24%)
At close: Aug 8, 2022 3:59 PM
1.58
-0.01 (-0.63%)
After-hours: Aug 8, 2022 7:30 PM EDT

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Net Income
-40.25-30.15-17.79-8.87
Depreciation & Amortization
0.170.180.150.05
Share-Based Compensation
2.681.570.731.07
Other Operating Activities
-0.950.851.971.39
Operating Cash Flow
-38.36-27.54-14.95-6.37
Capital Expenditures
-0.01-0.05-1.33-0.22
Change in Investments
00.23-0.25-0.03
Investing Cash Flow
-0.010.18-1.58-0.25
Share Issuance / Repurchase
33.3352.9200.02
Other Financing Activities
007.0725.4
Financing Cash Flow
33.3352.927.0825.42
Net Cash Flow
-5.0325.56-9.4618.8
Free Cash Flow
-38.36-27.59-16.28-6.59
Free Cash Flow Margin
-1094.15%-743.96%-697.51%-
Free Cash Flow Per Share
-2.66-2.80-3.27-1.34
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).